Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology

dc.contributor.authorLongatto, Adhemarpor
dc.contributor.authorNaud, Paulopor
dc.contributor.authorDerchain, Sophie F. M.por
dc.contributor.authorRoteli-Martins, Cecíliapor
dc.contributor.authorTatti, Sílviopor
dc.contributor.authorHammes, Luciano Serpapor
dc.contributor.authorSarian, Luis Otaviopor
dc.contributor.authorEržen, Mojcapor
dc.contributor.authorBranca, Margheritapor
dc.contributor.authorde Matos, Jean Carlospor
dc.contributor.authorGontijo, Renatapor
dc.contributor.authorMaeda, Marina Y. S.por
dc.contributor.authorLima, Temístoclespor
dc.contributor.authorCosta, Silvanopor
dc.contributor.authorSyrjänen, Stinapor
dc.contributor.authorSyrjänen, Karipor
dc.date.accessioned2020-10-09T09:18:06Z
dc.date.embargo10000-01-01
dc.date.issued2012-05
dc.description.abstractWe sought to evaluate the performance of diagnostic tools to establish an affordable setting for early detection of cervical cancer in developing countries. We compared the performance of different screening tests and their feasibility in a cohort of over 12,000 women: conventional Pap smear, liquid-based cytology, visual inspection with acetic acid (VIA), visual inspection with Iodine solution (VILI), cervicography, screening colposcopy, and high-risk human papillomavirus (HPV) testing (HR-HPV) collected by physician and by self-sampling. HR-HPV assay collected by the physician has the highest sensitivity (80 %), but high unnecessary referrals to colposcopy (15.1 %). HR-HPV test in self-sampling had a markedly lower (57.1 %) sensitivity. VIA, VILI, and cervicography had a poor sensitivity (47.4, 55, and 28.6 %, respectively). Colposcopy presented with sensitivity of 100 % in detecting CIN2+, but the lowest specificity (66.9 %). Co-testing with VIA and VILI Pap test increased the sensitivity of stand-alone Pap test from 71.6 to 87.1 % and 71.6 to 95 %, respectively, but with high number of unnecessary colposcopies. Co-testing with HR-HPV importantly increased the sensitivity of Pap test (to 86 %), but with high number of unnecessary colposcopies (17.5 %). Molecular tests adjunct to Pap test seems a realistic option to improve the detection of high-grade lesions in population-based screening programs.por
dc.description.sponsorshipEuropean Commission, INCO-DEV Programme (contract# ICA4-CT-2001-10013). The generous contribution of DIGENE Corporation (USA) donating the HCII tests at our disposal is gratefully acknowledged.por
dc.distributioninternationalpor
dc.identifier.citationLongatto-Filho, A., Naud, P., Derchain, S. F., Roteli-Martins, C., Tatti, S., Hammes, L. S., ... & Gontijo, R. (2012). Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology. Virchows Archiv, 460(6), 577-585por
dc.identifier.doi10.1007/s00428-012-1242-ypor
dc.identifier.eissn1432-2307
dc.identifier.issn0945-6317
dc.identifier.pmid22562132por
dc.identifier.urihttps://hdl.handle.net/1822/67421
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherSpringerpor
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s00428-012-1242-ypor
dc.rightsrestrictedAccesspor
dc.subjectCancer preventionpor
dc.subjectPap testpor
dc.subjectHybrid capturepor
dc.subjectColposcopypor
dc.subjectScreening programpor
dc.subject.fosCiências Médicas::Medicina Básicapor
dc.subject.wosScience & Technologypor
dc.titlePerformance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathologypor
dc.typearticlepor
dspace.entity.typePublicationen
oaire.citationEndPage585por
oaire.citationIssue6por
oaire.citationStartPage577por
oaire.citationVolume460por
sdum.journalVirchows Archivpor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
Longatto-filho-2012-Performance-characteristics-of-pap-.pdf
Tamanho:
175.87 KB
Formato:
Adobe Portable Document Format